Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial

INTRODUCTION: There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. Our objective was to evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Menaka, Adhikari, Neill K. J., Ostermann, Marlies, Heels-Ansdell, Diane, Douketis, James D., Skrobik, Yoanna, Qushmaq, Ismael, Meade, Maureen, Guyatt, Gordon, Geerts, William, Walsh, Michael W., Crowther, Mark A., Friedrich, Jan O., Burry, Lisa, Bellomo, Rinaldo, Brandão da Silva, Nilton, Costa Filho, Rubens, Cox, Michael J., Alves Silva, Suzana, Cook, Deborah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983525/
https://www.ncbi.nlm.nih.gov/pubmed/29856817
http://dx.doi.org/10.1371/journal.pone.0198285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983525/
https://www.ncbi.nlm.nih.gov/pubmed/29856817
http://dx.doi.org/10.1371/journal.pone.0198285

Ejemplares similares